This report contains market size and forecasts of Aneurysmal Subarachnoid Hemorrhage in Global, including the following market information:
Global Aneurysmal Subarachnoid Hemorrhage Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Aneurysmal Subarachnoid Hemorrhage market was valued at 156.3 million in 2020 and is projected to reach US$ 168.9 million by 2027, at a CAGR of 2.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aneurysmal Subarachnoid Hemorrhage companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aneurysmal Subarachnoid Hemorrhage Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Aneurysmal Subarachnoid Hemorrhage Market Segment Percentages, By Type, 2020 (%)
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
China Aneurysmal Subarachnoid Hemorrhage Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Aneurysmal Subarachnoid Hemorrhage Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others
Global Aneurysmal Subarachnoid Hemorrhage Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Aneurysmal Subarachnoid Hemorrhage Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Aneurysmal Subarachnoid Hemorrhage Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Aneurysmal Subarachnoid Hemorrhage Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Aneurysmal Subarachnoid Hemorrhage Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aneurysmal Subarachnoid Hemorrhage Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Aneurysmal Subarachnoid Hemorrhage Overall Market Size
2.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size: 2021 VS 2027
2.2 Global Aneurysmal Subarachnoid Hemorrhage Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Aneurysmal Subarachnoid Hemorrhage Players in Global Market
3.2 Top Global Aneurysmal Subarachnoid Hemorrhage Companies Ranked by Revenue
3.3 Global Aneurysmal Subarachnoid Hemorrhage Revenue by Companies
3.4 Top 3 and Top 5 Aneurysmal Subarachnoid Hemorrhage Companies in Global Market, by Revenue in 2020
3.5 Global Companies Aneurysmal Subarachnoid Hemorrhage Product Type
3.6 Tier 1, Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Players in Global Market
3.6.1 List of Global Tier 1 Aneurysmal Subarachnoid Hemorrhage Companies
3.6.2 List of Global Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Aneurysmal Subarachnoid Hemorrhage Market Size Markets, 2021 & 2027
4.1.2 Computed Tomography (CT) Scan
4.1.3 Magnetic Resonance Imaging (MRI)
4.1.4 Lumbar Puncture
4.1.5 Xanthochromia
4.1.6 Cerebral Angiography
4.1.7 Transcranial Doppler Ultrasound
4.2 By Type - Global Aneurysmal Subarachnoid Hemorrhage Revenue & Forecasts
4.2.1 By Type - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2021
4.2.2 By Type - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2022-2027
4.2.3 By Type - Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Aneurysmal Subarachnoid Hemorrhage Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Aneurysmal Subarachnoid Hemorrhage Revenue & Forecasts
5.2.1 By Application - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2021
5.2.2 By Application - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2022-2027
5.2.3 By Application - Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Aneurysmal Subarachnoid Hemorrhage Market Size, 2021 & 2027
6.2 By Region - Global Aneurysmal Subarachnoid Hemorrhage Revenue & Forecasts
6.2.1 By Region - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2021
6.2.2 By Region - Global Aneurysmal Subarachnoid Hemorrhage Revenue, 2022-2027
6.2.3 By Region - Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2027
6.3.2 US Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.3.3 Canada Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.3.4 Mexico Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2027
6.4.2 Germany Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.3 France Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.4 U.K. Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.5 Italy Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.6 Russia Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.7 Nordic Countries Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.4.8 Benelux Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2027
6.5.2 China Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.5.3 Japan Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.5.4 South Korea Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.5.5 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.5.6 India Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2027
6.6.2 Brazil Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.6.3 Argentina Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Revenue, 2016-2027
6.7.2 Turkey Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.7.3 Israel Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.7.4 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
6.7.5 UAE Aneurysmal Subarachnoid Hemorrhage Market Size, 2016-2027
7 Players Profiles
7.1 Edge Therapeutics
7.1.1 Edge Therapeutics Corporate Summary
7.1.2 Edge Therapeutics Business Overview
7.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.1.4 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.1.5 Edge Therapeutics Key News
7.2 Actelion Pharmaceuticals
7.2.1 Actelion Pharmaceuticals Corporate Summary
7.2.2 Actelion Pharmaceuticals Business Overview
7.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.2.4 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.2.5 Actelion Pharmaceuticals Key News
7.3 Arbor Pharmaceuticals
7.3.1 Arbor Pharmaceuticals Corporate Summary
7.3.2 Arbor Pharmaceuticals Business Overview
7.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.3.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.3.5 Arbor Pharmaceuticals Key News
7.4 Mayfield Brain & Spine
7.4.1 Mayfield Brain & Spine Corporate Summary
7.4.2 Mayfield Brain & Spine Business Overview
7.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.4.4 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.4.5 Mayfield Brain & Spine Key News
7.5 Europa Group
7.5.1 Europa Group Corporate Summary
7.5.2 Europa Group Business Overview
7.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.5.4 Europa Group Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.5.5 Europa Group Key News
7.6 GE
7.6.1 GE Corporate Summary
7.6.2 GE Business Overview
7.6.3 GE Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.6.4 GE Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.6.5 GE Key News
7.7 Philips
7.7.1 Philips Corporate Summary
7.7.2 Philips Business Overview
7.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.4.4 Philips Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.7.5 Philips Key News
7.8 Siemens
7.8.1 Siemens Corporate Summary
7.8.2 Siemens Business Overview
7.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.8.4 Siemens Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.8.5 Siemens Key News
7.9 Trivitron
7.9.1 Trivitron Corporate Summary
7.9.2 Trivitron Business Overview
7.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.9.4 Trivitron Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.9.5 Trivitron Key News
7.10 Toshiba
7.10.1 Toshiba Corporate Summary
7.10.2 Toshiba Business Overview
7.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Major Product Offerings
7.10.4 Toshiba Aneurysmal Subarachnoid Hemorrhage Revenue in Global (2016-2021)
7.10.5 Toshiba Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Aneurysmal Subarachnoid Hemorrhage Market Opportunities & Trends in Global Market
Table 2. Aneurysmal Subarachnoid Hemorrhage Market Drivers in Global Market
Table 3. Aneurysmal Subarachnoid Hemorrhage Market Restraints in Global Market
Table 4. Key Players of Aneurysmal Subarachnoid Hemorrhage in Global Market
Table 5. Top Aneurysmal Subarachnoid Hemorrhage Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Aneurysmal Subarachnoid Hemorrhage Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Aneurysmal Subarachnoid Hemorrhage Revenue Share by Companies, 2016-2021
Table 8. Global Companies Aneurysmal Subarachnoid Hemorrhage Product Type
Table 9. List of Global Tier 1 Aneurysmal Subarachnoid Hemorrhage Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type